Antibody response in people aged over 80 is three-and-a-half times greater in those who have the second dose of the Pfizer COVID-19 vaccine after 12 weeks […]
On May 5, Health Canada approved a COVID-19 vaccine for use in children aged 12-15 years. The United States Food and Drug Administration quickly followed suit, […]
The Therapeutic Goods Administration (TGA) yesterday revealed there have been six reports of Guillain-Barré syndrome in Australia following the AstraZeneca COVID vaccine.
New research has shown that people with type 1 diabetes may have features of premature heart disease induced by the condition often before they even get […]